ArriVent BioPharma
AVBP | NASDAQ
$11.56
-$1.45 (-11.15%)
At close: Nov 16, 2026, 4:00 PM ET
$11.56
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
ArriVent BioPharma Statistics
Key statistics explainedMarket Data
$597.92M
$204.95M
1.35
1.02M
49.53M
18.16%
N/A
NASDAQ
US04272N1028
Price Performance
-30.6%
-60.1%
-57.3%
-42.5%
-44.1%
N/A
N/A
-30.6%
-44.1%
N/A
-14.2%
Valuation
-3.16
N/A
-0.35
0.31
119.58
90.50
1.52
-3.91
-3.41
-3.74
40.99
-1.19
-1.19
-1.34
-31.7%
-25.6%
-29.3%
Financial Health
$393.22M
$256K
$393.22M
$417.09M
17.64
17.64
0.00
-0.00
-0.00
-597.04
0.00
15.07
4
Margins & Profitability
100.0%
-3620.0%
-3442.7%
-3381.4%
-3056.8%
-3501.9%
445.1%
-14.6%
Returns
-40.5%
-48.6%
-46.0%
-46.0%
-40.5%
Historical Growth (CAGR)
150.0%
N/A
N/A
-18.2%
N/A
N/A
-34.2%
N/A
N/A
Analyst Forecasts
Buy
8
14.8%
175.6%
Mar 4, 2027
-$0.96
23.1%
$6.05M
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$27.00
133.6%
Cash Flow
$-152.84M
$-152.84M
$-175.1M
-$3.09
-$3.09
-3056.8%
Income Statement
$5M
$5M
$-181M
$-172.13M
$-169.07M
-$3.66
$64.94K
$-2.2M
77
Add to Watchlist
Select watchlists to add or remove AVBP